Clinical Trial Update: OH2 Oncolytic Viral Therapy Via Transcatheter Intraarterial Infusion in Patients with Advanced Liver Cancer [Phase 1]

View source ↗

Summary

This clinical trial update reports that OH2, an oncolytic viral therapy, is being evaluated for advanced liver cancer via transarterial infusion in a Phase 1 st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• OH2

Snippet

Sponsor: Binhui Biopharmaceutical Co., Ltd. | Conditions: Advanced Liver Cancer | Phase 1 | Status: RECRUITING